BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17064970)

  • 1. The interaction between plasminogen and antiplasmin variants as studied by surface plasmon resonance.
    Wang H; Karlsson A; Sjöström I; Wiman B
    Biochim Biophys Acta; 2006 Nov; 1764(11):1730-4. PubMed ID: 17064970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of amino acids in antiplasmin involved in its noncovalent 'lysine-binding-site'-dependent interaction with plasmin.
    Wang H; Yu A; Wiman B; Pap S
    Eur J Biochem; 2003 May; 270(9):2023-9. PubMed ID: 12709062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
    Nilsson T; Sjöholm I; Wiman B
    Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of plasminogen to hepatocytes isolated from injured mouse liver and nonparenchymal-cell-dependent proliferation of hepatocytes.
    Okada K; Ueshima S; Kawao N; Okamoto C; Matsuo K; Akao M; Seki T; Ariga T; Tanaka M; Matsuo O
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):503-11. PubMed ID: 18685433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity-chromatographic purification of human alpha 2-antiplasmin.
    Wiman B
    Biochem J; 1980 Oct; 191(1):229-32. PubMed ID: 6907016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of the carbohydrate side chains of human plasminogen in its interaction with alpha 2-antiplasmin and fibrin.
    Lijnen HR; Van Hoef B; Collen D
    Eur J Biochem; 1981 Nov; 120(1):149-54. PubMed ID: 7308211
    [No Abstract]   [Full Text] [Related]  

  • 8. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of catalytic activity of plasminogen by monoclonal antibody IV-Ic in the presence of divalent metal cations and alpha2-antiplasmin.
    Sokolovskaya LI; Slominskii AY; Volkov GL
    Biochemistry (Mosc); 2006 Jun; 71(6):627-33. PubMed ID: 16827654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topography of the high-affinity lysine binding site of plasminogen as defined with a specific antibody probe.
    Miles LA; Plow EF
    Biochemistry; 1986 Nov; 25(22):6926-33. PubMed ID: 3099830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide.
    Frank PS; Douglas JT; Locher M; Llinás M; Schaller J
    Biochemistry; 2003 Feb; 42(4):1078-85. PubMed ID: 12549929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on a form of alpha 2-antiplasmin in plasma which does not interact with the lysine-binding sites in plasminogen.
    Wiman B; Nilsson T; Cedergren B
    Thromb Res; 1982 Oct; 28(2):193-9. PubMed ID: 6817454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation.
    Epple G; Langfeld K; Baier M; Holzhütter HG; Schleuning WD; Köttgen E; Gessner R; Praus M
    Thromb Haemost; 2004 Mar; 91(3):465-72. PubMed ID: 14983221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levels of plasminogen and alpha 2-antiplasmin in blood of patients with prostatic tumor].
    Zietek Z; Iwan-Zietek I; Kotschy M; Tyloch F
    Pol Tyg Lek; 1996 Feb; 51(6-9):86-8. PubMed ID: 8756739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-plasminogen like molecule in septic patients.
    Kordich LC; Porterie VP; Lago O; Bergonzelli GE; Sassetti B; Sanchez Avalos JC
    Thromb Res; 1987 Sep; 47(5):553-60. PubMed ID: 2445046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.
    Lu BG; Sofian T; Law RH; Coughlin PB; Horvath AJ
    J Biol Chem; 2011 Jul; 286(28):24544-52. PubMed ID: 21543325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Binding of alpha-2-antiplasmin with fibrinogen/fibrin and their fragments independent of factor XIII].
    Zadorozhna MB; Hrynenko TV; Iusova OI; Volkov HL
    Ukr Biokhim Zh (1999); 2004; 76(5):71-7. PubMed ID: 16100900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two forms of alpha 2-antiplasmin: post-traumatic changes in the rat.
    Högstorp H; Carlin G
    Ups J Med Sci; 1987; 92(1):79-83. PubMed ID: 2438835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two forms of alpha 2-antiplasmin: differences in KAV and isoelectric point.
    Högstorp H; Jacobsson H; Wallin R; Saldeen T
    Thromb Res; 1984 Sep; 35(5):559-65. PubMed ID: 6484898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against plasminogen and alpha-2-antiplasmin: binding to native and modified antigens.
    Hattey E; Wojta J; Binder BR
    Thromb Res; 1987 Mar; 45(5):485-95. PubMed ID: 2438800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.